Bone disease with persistent reduced bone mineralisation is common in premature infants. To test the hypothesis that enhancement of nutritional intake after discharge from hospital improves bone mineralisation, 31 formula fed preterm infants were randomly assigned to receive standard or multinutrient enriched milk from the time of discharge. The calcium and phosphorus contents of the enriched milk were 70 and 35 mg/100 ml v 35 and 29 mg/100 ml for the standard formula. Bone mineral content was measured before discharge from hospital in 21 of the infants; there was no difference in the bone mineral content between the groups at that time (35 mg/cm for the two groups). There was a significant increase in bone mineral content for those infants receiving the enriched v standard formula at 3 and 9 months corrected postnatal age: at 3 months the bone mineral content was 83 v 63 mg/cm and at 9 months 115 v 95 mg/cm. The difference between the groups was thus maintained although not increased at a corrected age of 9 months, when the bone mineral content of infants fed the enriched but not the standard formula was no longer significantly different Bone disease, characterised by disturbances in mineral metabolism,1-3 increased plasma alkaline phosphatase activity,4 reduced bone mineralisation,5 6 and abnormal bone remodelling7 with reduced growth velocity45 has been widely reported for preterm infants. Dietary insufficiency, particularly of the bone minerals calcium and phosphorus, has been identified as a significant aetiological factor,8-'0 and studies using mineral supplemented formulas during the period in hospital have shown that in utero accretion rates for bone minerals can be achieved in well preterm infants fed by mouth.1 -13 Nevertheless, many preterm infants still leave hospital retarded in growth, and with under mineralised bones. This study was undertaken to test the hypothesis that prolonged nutritional supplementation after discharge from hospital using a formula specifically enriched in the key ingredients likely to enhance bone development (protein, energy, calcium, and phosphorus) would result in improved bone mineralisation up to a corrected postnatal age of 9 months in formula fed infants born preterm.
Bone disease, characterised by disturbances in mineral metabolism,1-3 increased plasma alkaline phosphatase activity,4 reduced bone mineralisation,5 6 and abnormal bone remodelling7 with reduced growth velocity45 has been widely reported for preterm infants. Dietary insufficiency, particularly of the bone minerals calcium and phosphorus, has been identified as a significant aetiological factor,8-'0 and studies using mineral supplemented formulas during the period in hospital have shown that in utero accretion rates for bone minerals can be achieved in well preterm infants fed by mouth.1 -13 Nevertheless, many preterm infants still leave hospital retarded in growth, and with under mineralised bones. This study was undertaken to test the hypothesis that prolonged nutritional supplementation after discharge from hospital using a formula specifically enriched in the key ingredients likely to enhance bone development (protein, energy, calcium, and phosphorus) would result in improved bone mineralisation up to a corrected postnatal age of 9 months in formula fed infants born preterm.
Subjects and methods
We recruited 31 preterm infants before discharge home from the neonatal intensive care unit. Inclusion criteria included weight less than 1850 g at birth and less than 300 g at entry to the study, age less than 100 days at discharge, freedom from major congenital malformations and diseases likely to influence growth and development, and formula rather than human milk fed during their stay in hospital. Ethical approval for the study was given by the Cambridge Health Authority and the Medical Research Council Dunn Nutrition Unit ethics committees.
Infants were randomised, after informed parental consent, to receive either a standard term formula (Farley's Ostermilk, Crookes Health Care), or a specially designed 'follow on preterm formula' (Farley's Premcare, manufactured to our specifications by Crookes Health Care). Full compositional details have been published previously14; potentially relevant differences are shown in table 1. The largest difference (in percentage terms) is in the mineral content of the two milks, but protein and energy are also increased in the enriched formula.
The randomisation was stratified by sex. The infants had all been in the neonatal intensive care unit of the Rosie Maternity Hospital, Cambridge before randomisation, and had had extensive data collection undertaken from birth. The infants were fed with the formula milk while still in hospital. They were visited at home fortnightly by a research nursing sister Tables 2 and 3 show the demographic and anthropometric data at trial entry and corrected ages of 3 and 9 months separated by diet group. The groups were well matched for gestational age, birth weight, and severity of initial respiratory illness. There were no significant differences in body weight, length, head circumference, or skinfold thickness at trial entry. Formula consumption was similar between the two groups. Details for the infants as a combined group have been published previously'4; were almost identical with those seen for the smaller groups above (difference in mean (95% confidence interval) bone mineral content of enriched and standard formula groups 20 (9 to 31) mg/cm and 21 (7 to 34 mg/cm) at each age respectively. The figure shows a graphical comparison of the bone mineral content of infants in this study with that of Cambridge infants born at term.'6 These data show that by 9 months the bone mineral content in infants fed the enriched diet was about two standard errors lower than in normal controls (figure). After adjusting for body size the bone mineral content in the enriched formula group was even closer to that of the normal controls. The adjustment for body size was performed by plotting the mean value for bone mineral content at the mean expected age for body weight for each group, as weight rather than length was independently associated with the bone mineral content.
We considered that the effect of the enriched formula on mineralisation might be explained by the greater growth rate and body size of infants fed this diet; it would be reasonable to expect that larger infants would have bigger bones and therefore more bone mineral. To explore this, we undertook multiple regression analysis with bone mineral content as the dependent variable and body weight, height, bone width, sex, and diet type (standard or enriched formula) as independent factors.
The diet after discharge was the factor most strongly associated with bone mineral content at 3 months (t=3-85; p<0001), exceeding the association with body weight (t=3-66; p<0002) and with bone width (t=2-65; p<0 02). At 9 months the diet after discharge was still independently associated with bone mineral content (t=2-62; p<003), though the effect of bone width was then much stronger (t=4 59; p<0-000 1). Thus, our data show that the effect of diet on bone mineralisation was independent of body size and bone width. It might also be expected that factors in the antenatal and immediate postdelivery period would also influence later bone mineral content. Further multiple regression analysis was undertaken with the bone mineral content at 3 and then at 9 months as the dependent variable. Gestation, birth weight, duration of ventilation (as a marker of the severity of illness), maximum plasma alkaline phosphatase activity, and whether or not the infant was small for gestation (less than the tenth centile) were included as additional independent variables (as well as those in the models above). Diet before discharge was not included in these models as infants in the study were uniformly fed preterm formula until near to discharge. Table 6 shows the results of stepwise multiple regression models, and lists those factors that had a significant independent relationship with the bone mineral content. For the 3 month data set, diet after discharge (receiving the enriched formula) was the most significant factor, followed by 3 month body weight and bone width. At 9 months the only independent factors were bone width, diet after discharge, and birth weight (in descending order of significance).
To exclude the possibility that in the 3 month model, body weight and bone width (at 3 
Discussion
We have shown in a prospective randomised double blind controlled study that preterm infants fed a special nutrient enriched formula as opposed to standard milk formula after discharge from hospital had a higher bone mineral content at 3 and 9 months corrected postnatal age. This effect was independent of body size.
After adjusting for a range of antenatal, neonatal, and anthropometric factors, diet after discharge from hospital was the factor which was most strongly related to bone mineral content at an age of 3 months. The difference in mineral accretion velocity was only significantly different between the groups over this first period, but the difference in bone mineral content between the standard and enriched formula fed groups was still maintained at 9 months. By a corrected postnatal age of 9 months the infants receiving the enriched but not the standard formula had a bone mineral content no longer significantly different from that expected for age, after adjusting for body size. The effect of dietary mineral supplementation on the bone mineralisation in preterm infants during the period in hospital has been studied extensively. A large number of studies support the view that an inadequate intake of bone mineral substrate (rather than vitamin D deficiency) is the principal factor in the aetiology of bone disease of prematurity.1 4 11-13 There have, however, been relatively few studies of the longer term follow up of infants born prematurely in terms of skeletal growth and bone mineralisation. In a previous study of the effect of early diet on later growth and development4 we showed that bone disease, as indicated by increased plasma alkaline phosphatase activity, was the factor most strongly associated with reduced body length at 18 months corrected postnatal age, with early diet (formula v unsupplemented human milk) also exerting a substantial independent effect.
Other groups have studied the bone mineral content of preterm infants after discharge from hospital.'7-19 Congdon et al found a rapid acceleration in the rate of mid-forearm bone mineralisation after discharge from hospital for infants born preterm up to a median corrected age of 10 weeks.'7 Chan and Mileur found higher values than ours at a corrected postnatal age of 3 months for preterm infants receiving term formula after discharge from hospital (95 mg/cm), but the infants' average bone mineral content at discharge was also substantially higher (52 mg/cm).18 Schanler et al reported the bone mineral content of infants born preterm at intervals up to 2 years of age. 19 The infants had received expressed milk from their mothers while in hospital, and then either continued with breast feeding or with a standard term formula according to parental choice after discharge from hospital. The results obtained from that non-randomised study are broadly similar to our own, with the infants receiving the formula milk having a greater bone mineral content at 6 months and 1 year of age than those receiving milk from their mothers. Bone mineralisation was similar in each group at the age of 2 years.
In this study, infants born at 27-34 weeks' gestation and fed on mineral enriched preterm formula in hospital showed poor bone mineralisation at discharge with a mean value of around 50% of that expected for their age after conception. Interestingly, we found the infants fed a standard formula after discharge had a markedly decreased bone mineral content even at 9 months after term, when the mean value was only 70% of that expected for age, and 76% after adjusting for body size. The corresponding values at 9 months for infants fed the enriched formula were 866% and 910%.
It was remarkable that at three months after term, the diet after discharge was the only clinical factor identified that related to the bone mineral content. At this age, we found no evidence that infants who were growth retarded at birth or who were more immature, sick, or had a higher peak alkaline phosphatase activity were at risk for developing more poorly mineralised bones. It is possible that such effects were missed because our cohort was relatively small and our selection criteria excluded infants with prolonged respiratory disease. Moreover, before discharge none of the infants were fed with unsupplemented human milk or standard formula which would supply low intakes of bone minerals. Nevertheless, it appears that the nature of the diet after discharge is highly influential for bone mineral accretion in infancy.
In this study the mean stay in hospital was only six weeks (a typical period of hospital stay for a very low birthweight preterm infant). In contrast, our infants received their formula after discharge for an average of 43 weeks. It should not be surprising, therefore, if nutrition policy after discharge proved to be at least as influential as hospital management in terms of later nutritional status.
The bone mineral content estimated by single photon absorptiometry correlates well with total body calcium measured by in vivo neutron activation analysis'6 and dual energy x ray absorptiometry20 in adults. Our results therefore suggest an overall increase in the total amount of bone mineral in the skeleton for those infants who received the enriched formula. A number of studies of fractures in childhood have shown that reduced bone mineralisation is a predisposing factor.2'-23 We have shown previously that although there was no overall increase in the risk of clinically presenting fractures up to the age of 5 years for infants born prematurely, there was a trend towards earlier presentation (at less than 2 years of age) for those born at less than 33 weeks' gestation.24 We speculate that the increased bone mineral content shown here for infants receiving the enriched formula might ameliorate that risk.
Bone mineralisation continues throughout childhood and into adolescence with a more rapid accretion of bone mineral during puberty.25 27 Helin et al reported that infants born prematurely had a reduced bone mineral content at follow up to an age of 16 years, but gave no information about early diet28; there are no similar data available for adults born preterm. This raises concern over the potential long term effect on skeletal development of prolonged undermineralisation during the first year of life. It is possible that inadequate provision of dietary calcium and phosphorus during this period when overall growth is normally at its most rapid might affect future bone growth and mineralisation. Clearly, long term follow up of premature infants randomised to different diets in the neonatal period is required to investigate this.
The home use of a multinutrient enriched rather than standard milk formula has improved skeletal growth and bone mineralisation in a group of preterm infants. Previously we reported that these infants, fed the same enriched formula, had improved weight gain and linear growth velocity without impaired feed tolerance. 14 This group of infants appears to have nutritional requirements which exceed the provisions of the routinely supplied standard term formula. We suggest the use of nutrient enriched postdischarge milk should now be considered for each preterm infant as they leave hospital. 
